Open Access DOI:10.23937/2572-3987.1510033
A Practical Guide to Prescribing Long-Acting Injectable Medications: Clinically Informed Technological Aspects and Algorithmic Approaches for Enhanced Understanding and Implementation in Clinical Practice
Minaal Khan, DO (2026), Najeeb Manalai, MD, Gul P. M. Osmani, MD, Allison Foroobar, MD, Daniel Nicholas, DO, Patricia Harrison, MD, Donna Carmosky, MD, Charles Scercy, MS, Beth Yanoff, MD and Partam Manalai, MD
Article Type: Review Article | First Published: 2024/11/30
It is very well documented and supported by the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study that patients with schizophrenia spectrum disorders do not adhere to medications adequately. Long-acting injectable (LAI) medications have been consistently shown to improve compliance with treatment in patients living with these disorders. However, the complexity of navigating the available long-acting injections and selective preference by providers has resulted in less-tha...
Open Access DOI:10.23937/2572-3987.1510032
Paxlovid's Double-Edged Sword: Treating COVID-19 and the Risk of Viral Load Rebound
Sarah Hughes, PharmD, Jessica Russo, PharmD, MBA and Kimberly Finley, PharmD, BCACP
Article Type: Review Article | First Published: 2024/11/29
Coronavirus disease 19 (COVID-19) is an infectious respiratory illness caused by SARS-CoV-2 virus that has caused more than 3 million deaths since its emergence as a public health emergency in January 2020 [1]. Through emergency efforts, pharmaceutical companies such as Pfizer, Moderna, and Johnson and Johnson were able to create vaccinations to reduce hospitalizations and death related to COVID-19. Until 2021, social distancing combined with N-95 masks and the primary series of vaccination were...
Open Access DOI:10.23937/2572-3987.1510031
Regulatory Harmonization of East African Communities: A Study on Selected Pharmaceutical Industries in Ethiopia, 2023
Daniel Waktole Guyassa, MSc, Zdeno Matta, PhD, and Tefera Tezera Negera, PhD
Article Type: Research Article | First Published: 2024/03/08
A qualitative and qualitative study design was employed in this study from twelve pharmaceutical industries. Using semi structured interview guides with adaptable probing techniqes were used for data collection in qualitative parts and self administered survey questionnaires were used for quantitative parts. A total of twelve study participants were involved in the qualitative study, and fourty three study participants were involved in the quantitative study....
